[Retracted] Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury

Table 2

Molecular docking results.

Target	PDB ID	Target structure	Active ingredients	Affinity (kcal·mol^−1)	Best-docked complex
TP53	6MY0		Quercetin; Kaempferol; Formononetin; Isorhamnetin	−7.4; −6.6; −7.3; −7.2
ESR1	6KN5		Quercetin; Kaempferol; Formononetin; Isorhamnetin	−7.3; −7.3; −7.0; −7.2
MYC	1EE4		Quercetin; Kaempferol; Formononetin; Isorhamnetin	−6.6; −7.0; −6.8; −6.9
HIF1A	3HQU		Quercetin; Kaempferol; Formononetin; Isorhamnetin	−6.8; −6.7; −6.6; −6.7
MAPK1	6G54		Quercetin; Kaempferol; Formononetin; Isorhamnetin	−7.3; −6.6; −6.5; −6.5